You do not have permission to delete messages in this group
Copy link
Report message
Show original message
Either email addresses are anonymous for this group or you need the view member email addresses permission to view the original message
to Barbara C. Jobst, Andy Connolly, Ashlee A. Robbins, Peter Horak, hospital...@googlegroups.com
Dr. Jobst,
Attached, find the report for R1037D's YC2 at LOTD1-2. The subject performed well on 29.2% of stimulation trials and 20.8% of nonstimulation trials. The difference is not significant with a p = 0.5.
You do not have permission to delete messages in this group
Copy link
Report message
Show original message
Either email addresses are anonymous for this group or you need the view member email addresses permission to view the original message
to Barbara C. Jobst, Andy Connolly, Ashlee A. Robbins, Peter Horak, hospital...@googlegroups.com
Dr. Jobst,
Attached, find the report for R1037D's two sessions of YC2 with stimulation at LOTD1-2. The subject performed well 25% of the time in both stimulation and nonstimulation trials. This results in a p = 1.0. The full report can be found on box.
You do not have permission to delete messages in this group
Copy link
Report message
Show original message
Either email addresses are anonymous for this group or you need the view member email addresses permission to view the original message
to Barbara C. Jobst, Andy Connolly, Ashlee A. Robbins, Peter Horak, hospital...@googlegroups.com
Dr. Jobst,
Please find attached the report for R1037D's three sessions of YC2 with stimulation at LOTD1-2. The current was lowered from 1 mA to 0.5 mA in the most recent session. The subject performed well on 48.6% of stimulated trials and 51.4% of non-stimulated trials, with a p=0.74.